<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
       <contributors>
          <authors>
             <author>Leonardi, O.</author>
             <author>Castro, G.</author>
             <author>Celona, L.</author>
             <author>Chines, F.</author>
             <author>Costanzo, G.</author>
             <author>Gammino, S.</author>
             <author>Malferrari, L.</author>
             <author>Massara, A.</author>
             <author>Maugeri, C.</author>
             <author>Neri, L.</author>
             <author>Odorici, F.</author>
             <author>Passarello, S.</author>
             <author>Reitano, R.</author>
             <author>Russo, F.</author>
             <author>Siliato, D.</author>
          </authors>
       </contributors>
       <titles>
          <title>
             Status and Perspectives of the Advanced Ion Source for Hadrontherapy (AISHa)
          </title>
       </titles>
       <publisher>JACoW Publishing</publisher>
       <pub-location>Geneva, Switzerland</pub-location>
       <abstract>
          The Advanced Ion Source for Hadrontherapy (AISHa) is a compact electron cyclotron resonance ion source (ECRIS) operating at 18 GHz designed and developed to generate high brightness multiply charged ion beams for hadrontherapy purposes. Its peculiarities make AISHa also a suitable choice for research and industrial applications. AISHa is able to produce more than 1400 µA O⁶⁺, 500 µA C⁴⁺, 5 mA He²⁺. In the framework of the INSpIRIT program and in collaboration with CNAO and GSI, new ion beam candidates for cancer treatment and material irradiation are being developed. A copy of the AISHa ion source is also being installed at CNAO to expand its potential in terms of ion beam production. AISHa is also the test-bench for several R&amp;D activities to increase ion source performance and for non-invasive plasma diagnostic purposes: an innovative active plasma chamber designed to increase plasma confinement by modifying plasma losses fluxes is under study together with a dedicated Optical Emission Spectroscopy diagnostics setup. In this work, we will discuss the status of AISHa together with the description of the forthcoming developments and perspectives.
       </abstract>
    </record>
  </records>
</xml>
